1 false false false false false false false false false true false false false false false false No description of principal activity 2023-02-01 Sage Accounts Production Advanced 2021 - FRS102_2021 xbrli:pure xbrli:shares iso4217:GBP SC586605 2023-02-01 2024-01-31 SC586605 2024-01-31 SC586605 2023-01-31 SC586605 bus:Director1 2023-02-01 2024-01-31 SC586605 core:WithinOneYear 2024-01-31 SC586605 core:WithinOneYear 2023-01-31 SC586605 core:RestatedAmount 2023-01-31 SC586605 bus:Micro-entities 2023-02-01 2024-01-31 SC586605 bus:AuditExempt-NoAccountantsReport 2023-02-01 2024-01-31 SC586605 bus:FullAccounts 2023-02-01 2024-01-31 SC586605 bus:SmallCompaniesRegimeForAccounts 2023-02-01 2024-01-31 SC586605 bus:PrivateLimitedCompanyLtd 2023-02-01 2024-01-31
COMPANY REGISTRATION NUMBER: SC586605
Callidus Biomolecules Limited
Filleted Unaudited Financial Statements
31 January 2024
Callidus Biomolecules Limited
Statement of Financial Position
31 January 2024
2024
2023
£
£
Called up share capital not paid
1,000
1,000
-------
-------
Fixed assets
1,906
642
-------
-------
Current assets
12,121
436
Creditors: amounts falling due within one year
5,900
59
--------
-------
Net current assets
6,221
377
-------
-------
Total assets less current liabilities
9,127
2,019
Accruals and deferred income
450
180
-------
-------
8,677
1,839
-------
-------
Capital and reserves
8,677
1,839
-------
-------
Notes to the financial statements
1. Employee numbers
The average number of persons employed by the company during the year amounted to 1 (2023: Nil).
For the year ending 31 January 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Director's responsibilities:
- The member has not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;
- The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
These financial statements have been prepared in accordance with the micro-entity provisions and have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.
These financial statements were approved by the board of directors and authorised for issue on 30 September 2024 , and are signed on behalf of the board by:
Dr D Ozanne
Director
Company registration number: SC586605
The company is a private company limited by shares, registered in Scotland. The address of the registered office is Ormsary Cottage, Oyne, Insch, Aberdeenshire, AB52 6QT.